Skip to content

Clinical trials

Phase 3 Respiratory Tract Diseases trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Tract Diseases Phase: Phase 3 Country / region: France Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20092
20111
20122
20131
20143
20162
20171
20181
20192
20201
20211
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated3
Recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca6
Assistance Publique - Hôpitaux de Paris2
United Therapeutics2
Vertex Pharmaceuticals Incorporated2
Aeris Therapeutics1
Bellus Health Inc. - a GSK company1
Eli Lilly and Company1
GlaxoSmithKline1
Hoffmann-La Roche1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Tract Diseases20
Lung Diseases15
Bronchial Diseases9
Lung Diseases, Obstructive8
Asthma7
Pathologic Processes4
Respiratory Tract Infections3
Carcinoma, Bronchogenic2
Carcinoma, Non-Small-Cell Lung2
Cardiovascular Diseases2

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.